Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 1:44 AM
Ignite Modification Date:
2025-12-25 @ 1:44 AM
NCT ID:
NCT01585194
Brief Title:
Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
Official Title:
Phase II Study of Nivolumab in Combination With Ipilimumab for Uveal Melanoma
Study:
NCT01585194
Protocol Section:
NCT01585194